Quarter Period Consolidated Statement Of Income

COSMOS Pharmaceutical Corporation - Filing #7730595

Concept 2017-06-01 to
2017-11-30
2016-06-01 to
2016-11-30
Quarter period consolidated statement of income
Statement of income
Net sales
270,835,000,000 JPY
247,044,000,000 JPY
Cost of sales
217,301,000,000 JPY
197,363,000,000 JPY
Gross profit (loss)
53,533,000,000 JPY
49,681,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
43,241,000,000 JPY
37,800,000,000 JPY
Operating profit (loss)
10,292,000,000 JPY
11,880,000,000 JPY
Non-operating income
Interest income
39,000,000 JPY
42,000,000 JPY
Non-operating income
1,714,000,000 JPY
1,607,000,000 JPY
Non-operating expenses
Interest expenses
45,000,000 JPY
50,000,000 JPY
Non-operating expenses
418,000,000 JPY
445,000,000 JPY
Ordinary profit (loss)
11,589,000,000 JPY
13,043,000,000 JPY
Extraordinary income
Extraordinary income
8,000,000 JPY
1,194,000,000 JPY
Extraordinary losses
Loss on disaster
JPY
193,000,000 JPY
Extraordinary losses
90,000,000 JPY
272,000,000 JPY
Profit (loss) before income taxes
11,507,000,000 JPY
13,965,000,000 JPY
Income taxes
3,726,000,000 JPY
5,282,000,000 JPY
Profit (loss)
7,781,000,000 JPY
8,683,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
7,781,000,000 JPY
8,683,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
0 JPY
-1,000,000 JPY
Remeasurements of defined benefit plans, net of tax
8,000,000 JPY
51,000,000 JPY
Other comprehensive income
9,000,000 JPY
50,000,000 JPY
Comprehensive income
7,790,000,000 JPY
8,734,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
7,790,000,000 JPY
8,734,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.